Answer
Ocrevus (ocrelizumab) 300 mg concentrate for solution for infusion is administered after dilution by intravenous infusion through a dedicated line, not subcutaneously or as an intravenous push or bolus.
Sources for this answer
- OCREVUS 300 mg concentrate for solution for infusionRoche Products Limited · emc · SmPC §4.2 Posology and method of administration · Version 20Document updated
Sources checked